Diverse immune evasion strategies by human cytomegalovirus

被引:3
|
作者
Vanessa Noriega
Veronika Redmann
Thomas Gardner
Domenico Tortorella
机构
[1] Mount Sinai School of Medicine,Department of Microbiology
来源
Immunologic Research | 2012年 / 54卷
关键词
Human cytomegalovirus; MHC antigen presentation; Immune evasion; Latency; Lytic infection; Unique short; Proteasome; Degradation;
D O I
暂无
中图分类号
学科分类号
摘要
Members of the Herpesviridae family have the capacity to undergo both lytic and latent infection to establish a lifelong relationship with their host. Following primary infection, human cytomegalovirus (HCMV) can persist as a subclinical, recurrent infection for the lifetime of an individual. This quiescent portion of its life cycle is termed latency and is associated with periodic bouts of reactivation during times of immunosuppression, inflammation, or stress. In order to exist indefinitely and establish infection, HCMV encodes a multitude of immune modulatory mechanisms devoted to escaping the host antiviral response. HCMV has become a paradigm for studies of viral immune evasion of antigen presentation by both major histocompatibility complex (MHC) class I and II molecules. By restricting the presentation of viral antigens during both productive and latent infection, HCMV limits elimination by the human immune system. This review will focus on understanding how the virus manipulates the pathways of antigen presentation in order to modulate the host response to infection.
引用
收藏
页码:140 / 151
页数:11
相关论文
共 50 条
  • [1] Diverse immune evasion strategies by human cytomegalovirus
    Noriega, Vanessa
    Redmann, Veronika
    Gardner, Thomas
    Tortorella, Domenico
    [J]. IMMUNOLOGIC RESEARCH, 2012, 54 (1-3) : 140 - 151
  • [2] Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency
    Sabbaghian, Mohammad
    Gheitasi, Hamidreza
    Fadaee, Manouchehr
    Javadi Henafard, Helia
    Tavakoli, Ahmad
    Shekarchi, Ali Akbar
    Poortahmasebi, Vahdat
    [J]. ARCHIVES OF VIROLOGY, 2024, 169 (08)
  • [3] Human cytomegalovirus immunity and immune evasion
    Jackson, Sarah E.
    Mason, Gavin M.
    Wills, Mark R.
    [J]. VIRUS RESEARCH, 2011, 157 (02) : 151 - 160
  • [4] Cytomegalovirus immune evasion
    Powers, C.
    DeFilippis, V.
    Malouli, D.
    Frueh, K.
    [J]. HUMAN CYTOMEGALOVIRUS, 2008, 325 : 333 - 359
  • [5] Immune evasion by cytomegalovirus - survival strategies of a highly adapted opportunist
    Hengel, H
    Brune, W
    Koszinowski, UH
    [J]. TRENDS IN MICROBIOLOGY, 1998, 6 (05) : 190 - 197
  • [6] Modulation of HLA Expression in Human Cytomegalovirus Immune Evasion
    Aifen Lin1
    [J]. Cellular & Molecular Immunology, 2007, (02) : 91 - 98
  • [7] Modulation of HLA expression in human cytomegalovirus immune evasion
    Aifen Lin
    Huihui Xu
    Weihua Yan
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2007, 4 (02) : 91 - 98
  • [8] Human cytomegalovirus retinitis: pathogenicity, immune evasion and persistence
    Scholz, M
    Doerr, HW
    Cinatl, J
    [J]. TRENDS IN MICROBIOLOGY, 2003, 11 (04) : 171 - 178
  • [9] Strategies for immune evasion by human tumor viruses
    Bussey, Kendra A.
    Brinkmann, Melanie M.
    [J]. CURRENT OPINION IN VIROLOGY, 2018, 32 : 30 - 39
  • [10] Immune evasion by human cytomegalovirus: lessons in immunology and cell biology
    Loenen, WAM
    Bruggeman, CA
    Wiertz, EJHJ
    [J]. SEMINARS IN IMMUNOLOGY, 2001, 13 (01) : 41 - 49